Bonus Presentations
Please note all sessions listed in Pacific Time. Agenda subject to change.
Thursday, April 16
7:15 am — 8:15 am
Breakfast & Non-CME/CE Bonus Presentation
Speaker: Justin Horowitz, PharmD
Program Summary: This patient case discussion will share information about a treatment option for ESA-naïve patients with lower-risk MDS, including an overview of the history of LR-MDS treatment, first-line efficacy and safety data from the COMMANDS phase 3 head-to-head trial, as well as dosing and titration.
Sponsored by Bristol Myers Squibb
Thursday, April 16
1:25 pm — 2:25 pm
Lunch & Non-CME/CE Bonus Presentation
IDHentifying Appropriate Patients with MDS or AML
Speaker: Jamie Koprivnikar, MD
Program Summary: Join us for a presentation focusing on key background information and unmet needs in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), including the role of isocitrate dehydrogenase-1 (IDH1) and the importance of molecular testing for treatment planning. This program is intended for medical doctors (eg, MDs) specializing in hematologic oncology or who may see patients with AML or MDS.
Sponsored by Servier Pharmaceuticals
Thursday, April 16
5:35 pm — 6:35 pm
Reception & Non-CME/CE Bonus Presentation
Learn About a Treatment Option for Patients with R/R NPM1-m AML
Speaker: Kiran Naqvi, MD
Learning Objectives: Recognize the unmet need and treatment challenges in relapsed or refractory NPM1-mutated AML; review efficacy and safety data of KOMZIFTI; and apply trial evidence to patient case scenarios to identify appropriate patients and guide treatment decisions.
Sponsored by Kura Oncology
Friday, April 17
7:30 am — 8:30 am
Breakfast & Non-CME/CE Bonus Presentation
Planning for Treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Speaker: Speaker: Vincent Vidaurri, PharmD
Sponsored by Stemline Therapeutics
Friday, April 17
10:20 am — 11:20 am
Refreshments & Non-CME/CE Bonus Presentation
Speaker: James McCloskey, MD
Sponsored by Takeda Oncology
Friday, April 17
1:00 pm — 2:00 pm
Lunch & Non-CME/CE Bonus Presentation
A Different Option in the Treatment of Transfusion-Dependent Anemia in Lower-Risk MDS
Speaker: James McCloskey, MD
Sponsored by Geron Corporation
Disclaimer: Bonus presentations are independently organized and not an official part of the Acute Leukemia Forum 2026. CME/CE credit is not provided for these sessions.